Voyager Therapeutics (VYGR) EBT Margin Growth (3y) (2018 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | -77,617.00 |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 4.49 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 28,548.00 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 146,420.00 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -2.39 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 119,010.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 515.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1,380.00 |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -31,214.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31,214.00 |
| Mar 31, 2026 | -115,686.00 |
| Dec 31, 2025 | -170,200.00 |
| Sep 30, 2025 | -25,043.00 |
| Jun 30, 2025 | 203,909.00 |
| Mar 31, 2025 | 276,329.00 |
| Dec 31, 2024 | -55,805.00 |
| Sep 30, 2024 | 165,205.00 |
| Jun 30, 2024 | 207,253.00 |
| Mar 31, 2024 | 33,546.00 |
| Dec 31, 2023 | 42,529.00 |
| Sep 30, 2023 | -63,714.00 |
| Jun 30, 2023 | -41,974.00 |
| Mar 31, 2023 | 21,523.00 |
| Dec 31, 2022 | 156,171.00 |
| Sep 30, 2022 | 11,634.00 |
| Jun 30, 2022 | -270,496.00 |
| Mar 31, 2022 | -271,717.00 |
| Dec 31, 2021 | 114,008.00 |
| Sep 30, 2021 | -71,969.00 |